arivis software product family to include APEER, under the trusted ZEISS brand

APEER and arivis are coming together to better serve customers by consolidating hardware- and data-agnostic software under the brand ZEISS arivis. The changes will take place in phases over the coming year, starting in April 2023. Customers can continue to expect the same level of quality and support. The name ZEISS arivis will represent an expanded software product line that includes cloud and AI solutions. This step is consistent with the fact that arivis AG is formally becoming a ZEISS legal entity and its name is being changed to Carl Zeiss Microscopy Software Center Rostock GmbH.

A new name and a new look

Starting April 2023, arivis will be rebranded under the trusted ZEISS brand. Vision4D will become ZEISS arivis Pro. VisionVR will become ZEISS arivis Pro VR. VisionHub will become ZEISS arivis Hub. APEER will become ZEISS arivis Cloud. The AI technology will be referred to as the arivis AI Toolkit. The rebranding will occur in phases, starting with product renaming and the arivis website, and followed by other product experiences at later dates.

By taking this step, ZEISS is embracing the growing importance of AI-driven software for data analysis. These changes provide users with a consolidated product family containing advanced technologies that help them to extract and visualize relevant data more efficiently regardless of its complexity. Whatever the source and format of the image, the products are highly integrated and can be of benefit to users in academia and across industries.

“ZEISS continues to expand its product offering with innovative solutions, developed in-house or acquired in line with our customer-centric strategy,” says Dr. Michael Albiez, CEO of Carl Zeiss Microscopy GmbH. “We invite our customers to join us in this new chapter of hardware- and data-agnostic software under the ZEISS arivis name, which is already renowned for its image analysis technology excellence.”

arivis AG becomes a 100% subsidiary of Carl Zeiss Microscopy GmbH

The new subsidiary will be called Carl Zeiss Microscopy Software Center Rostock GmbH. Christian Götze and Andreas Suchanek act as managing directors. Employees are working together to take collaboration to a new level, creating a single enhanced team for the product line that will continue to lead innovation. “With the portfolio expansion, the integrated, scalable and hardware-agnostic ZEISS arivis platform will be even more competitive as it continues to help researchers gain reliable results with enhanced throughput, accelerated by cutting-edge AI technology”, says Andreas Suchanek, Managing Director, Carl Zeiss Microscopy Software Center Rostock GmbH.

About ZEISS

ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totaling 8.8 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology and Consumer Markets (status: 30 September 2022).

For its customers, ZEISS develops, produces and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.

With a portfolio aligned with future growth areas like digitalization, healthcare and Smart Production and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company's significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS' technology and market leadership. ZEISS invests 13 percent of its revenue in research and development – this high level of expenditure has a long tradition at ZEISS and is also an investment in the future.

With over 38,000 employees, ZEISS is active globally in almost 50 countries with around 30 production sites, 60 sales and service companies and 27 research and development facilities (status: 30 September 2022). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG.

ZEISS Research Microscopy Solutions

ZEISS Research Microscopy Solutions is the world's only one-stop manufacturer of light, electron, X-ray and ion microscope systems and offers solutions for correlative microscopy. The portfolio comprises of products and services for life sciences, materials and industrial research, as well as education and clinical practice. The unit is headquartered in Jena. Additional production and development sites are located in Oberkochen and Munich, as well as in Cambourne (UK) and Dublin (USA). ZEISS Research Microscopy Solutions is part of the Industrial Quality & Research segment.

Carl Zeiss Microscopy Software Center Rostock GmbH (formerly arivis AG)

The Carl Zeiss Microscopy Software Center Rostock GmbH offers a scientific image analysis ecosystem to researchers and companies engaged in all aspects of life science - from basic research and discovery to application. With a broad portfolio and an experienced team, the ZEISS arivis product family can fulfill both industrial and academic requirements. The software platform leverages innovative AI technologies to provide efficient and scalable applications. Customers include biotech companies, leading medical device and pharmaceutical companies, CROs and internationally renowned research institutes and universities.

ZEISS arivis Cloud (formerly APEER)

A team of ZEISS software experts developed a cloud solution that helps researchers overcome their image analysis challenges through end-to-end automation and efficient collaboration. At the core of the technology is the user-friendly arivis AI Toolkit, which can be used to train models to enable automated segmentation and analysis of complex image data, without the need to code. These software products make deep learning and machine learning accessible to everyone. The AI technology enables biotech and pharmaceutical scientists to accelerate R&D and commercialization by using the latest image analysis methods.

Recent news from ZEISS